News Gist .News

Articles | Politics | Finance | Stocks | Crypto | AI | Technology | Science | Gaming | PC Hardware | Laptops | Smartphones | Archive

Chart Industries Full Year 2024 Earnings: Misses Expectations

Chart Industries' full-year 2024 earnings exceeded analyst expectations, with revenue growing by 24% to US$4.16 billion and net income increasing by US$174.2 million to US$194.8 million. The company's profit margin expanded to 4.7%, driven by higher revenue, while earnings per share (EPS) rose to US$4.62, surpassing analyst estimates by 26%. Despite the positive results, revenue missed analyst expectations by 1.5%.

See Also

Ufp Industries Full Year 2024 Earnings: Eps Misses Expectations Δ1.85

UFP Industries' full-year 2024 earnings report fell short of analyst estimates, with revenue and profit margins taking a hit due to lower sales. The company's primary driver of revenue came from its Retail segment, but costs of sales and general & administrative expenses weighed heavily on earnings. Despite forecasted growth in revenue for the next two years, UFP Industries' shares have taken a hit, highlighting the importance of considering investment risks.

Bucher Industries Full Year 2024 Earnings: EPS Misses Expectations Δ1.85

Bucher Industries' full-year 2024 earnings fell short of expectations, with revenue declining 12% and net income dropping 36%. The company's profit margin also decreased to 7.2%, primarily due to lower revenue. Analysts had forecast a more resilient performance from the Swiss Machinery industry.

Rogers Full Year 2024 Earnings: Eps Misses Expectations Δ1.85

Rogers' full year 2024 earnings missed expectations, with revenue down 8.6% from the previous year and net income declining by 54%. The company's profit margin also decreased, while earnings per share (EPS) fell short of analyst estimates. Despite this, Rogers is forecasting a 3.4% average annual growth in revenue over the next two years.

e.on Full Year 2024 Earnings: Revenue Lags Amid Profit Growth Δ1.84

E.ON's full-year 2024 earnings revealed a profit margin of 4.8%, up from 0.5% in the previous year, driven by lower expenses and higher net income of €4.53b. The company's earnings per share (EPS) exceeded analyst estimates by 62%. However, revenue missed analyst expectations by 9.8%, coming in at €93.5b, down 1.6% from FY 2023.

Marchex Full Year 2024 Earnings: EPS Misses Expectations Δ1.84

Marchex reported a revenue of $48.1 million for the full year 2024, reflecting a 3.6% decline from the previous year, while net losses narrowed to $4.95 million. Despite these figures being largely in line with analyst estimates, the company's earnings per share missed expectations by 10%. Looking ahead, Marchex anticipates a modest revenue growth of 1.3% per annum over the next two years, lagging behind the broader media industry's forecasted growth of 2.7%.

South Bow Full Year 2024 Earnings: EPS Misses Expectations Δ1.84

South Bow reported a revenue increase to US$2.12 billion for the full year 2024, reflecting a 5.7% growth from the previous year. However, net income fell by 28% to US$316 million, resulting in a profit margin decrease from 22% to 15%, primarily due to rising expenses. The company's earnings per share (EPS) of US$1.52 missed analyst expectations by 15%, and future revenue growth is projected to remain flat, contrasting with the broader industry forecast.

Par Technology Full Year 2024 Earnings: Eps Beats Expectations, Revenues Lag Δ1.84

PAR Technology's full year 2024 earnings beat analyst expectations, but revenue missed estimates by 16%, with a net loss widening by 29% from the previous year. The company's shares have increased by 10% over the past week, driven by its strong EPS performance. However, the revenue decline and widening losses raise concerns about the company's financial health.

FIGS Full Year 2024 Earnings: Beats Expectations Δ1.84

FIGS reported a full-year revenue of $555.6 million for 2024, marking a 1.8% increase from the previous year, despite a significant drop in net income by 88%. The company's earnings per share surpassed analyst expectations, yet the profit margin fell to 0.5%, indicating rising expenses that have affected overall profitability. Looking ahead, FIGS anticipates an average revenue growth of 3.1% per year over the next three years, which lags behind the expected growth of the luxury industry in the U.S.

Holcim Full Year 2024 Earnings Miss Expectations Δ1.84

Holcim's full-year 2024 results missed analyst expectations, with revenue declining 2.2% to CHF26.4 billion and net income falling 3.8%. The company's profit margin remained steady at 11%, but earnings per share (EPS) missed estimates by 7.1%. Looking ahead, Holcim forecasts average annual revenue growth of 4.7% over the next three years.

Inchcape Full Year 2024 Earnings: EPS Beats Expectations Δ1.84

Inchcape's Full Year 2024 earnings report revealed a revenue decline of 19% to UK£9.26b, largely attributed to the negative impact of cost of sales amounting to 83% of total revenue. The company's net income remained flat at UK£271.0m, while its profit margin increased to 2.9%, driven by lower expenses. Earnings per share (EPS) surpassed analyst estimates by 47%.

WisdomTree Full Year 2024 Earnings: EPS Misses Expectations Δ1.83

WisdomTree's full-year 2024 earnings missed analyst estimates by 17%, with revenue up 23% from the previous year and net income down 48%. The company's profit margin declined to 12%, a significant drop from 27% in FY 2023. Despite this, WisdomTree's shares have been impacted, falling 1.7% from a week ago.

Clariant Full Year 2024 Earnings: EPS Misses Expectations Δ1.83

Clariant's full-year 2024 earnings missed expectations, with revenue down 5.1% from FY 2023 and net income up 45%. The company's profit margin increased to 5.9%, driven by lower expenses, but the earnings per share (EPS) fell short of analyst estimates. Despite this, revenue is forecast to grow at a slower pace than the Chemicals industry in Switzerland over the next three years.

Avepoint Full Year 2024 Earnings: Eps Misses Expectations Δ1.83

AvePoint's full-year 2024 earnings failed to meet expectations, with revenue surging 22% from the previous year but net losses widening by 34%. The company's shares have taken a hit, falling 16% from a week ago. AvePoint's performance is part of the broader American software industry, which has seen growth forecasts of 12% per annum.

Intrusion Full Year 2024 Earnings: Eps Beats Expectations, Revenues Lag Δ1.83

The company's earnings per share (EPS) exceeded analyst estimates by 5.8%, despite revenue missing forecasts by 4.2%. Intrusion's net loss narrowed by 44% from the previous year, while its shares are down 31% from a week ago. The company's financial performance is expected to be closely watched in the coming months.

BCE Full Year 2024 Earnings: EPS Misses Expectations Δ1.83

BCE's full-year 2024 earnings per share (EPS) missed analyst estimates by a significant margin, with the actual figure coming in at CA$0.18 compared to expectations of CA$2.28. The company's net income plummeted 92% from the previous year, resulting in a profit margin of just 0.7%. Revenue was in line with analyst estimates but still down 1.1% from the prior year.

Mosaic Full Year 2024 Earnings: Eps Misses Expectations Δ1.82

Mosaic's full-year 2024 earnings results show a significant decline, with revenue down 19% from the previous year and net income plummeting 85%. The company's profit margin has also decreased substantially, impacting its ability to generate earnings. Despite revenue growth forecasts for the next three years, the current performance is a cause for concern.

IMCD Full Year 2024 Earnings: In Line With Expectations Δ1.82

IMCD's full year 2024 earnings are in line with expectations, driven by a significant increase in revenue of 6.4% from the previous year, reaching €4.75 billion. The company's net income decreased by 4.8% to €278.2 million, primarily due to higher expenses. Despite this decline, IMCD's profit margin has dropped to 5.9%, a decrease from 6.5% in the previous year.

Amphastar Pharmaceuticals Full Year 2024 Earnings: Eps Misses Expectations Δ1.82

Amphastar Pharmaceuticals' full-year 2024 earnings per share (EPS) missed analyst estimates by 7.4%, despite revenue growth of 14% from the previous year. The company's net income rose 16% to US$159.5m, with a profit margin of 22%. Amphastar's shares have declined 9.1% from a week ago.

Cronos Group Full Year 2024 Earnings: Revenue Beats Expectations, Eps Lags Δ1.82

Cronos Group's full year 2024 earnings report shows revenue growth of 35% compared to the previous year, with a net income of US$41.1m, but missing analyst estimates by 2.0%. The company's profit margin has increased to 35%, and earnings per share (EPS) have declined to US$0.11, down from a loss of US$0.18 in the previous year. Revenue growth is forecasted to be 11% p.a. over the next three years.

Intershop Holding's Full Year 2024 Earnings: Revenue Declines, but Eps Surpasses Expectations Δ1.82

Intershop Holding's full year 2024 earnings reveal a revenue decline of 37% from the previous year, but an impressive surge in earnings per share (EPS) to CHF12.74, up 42% from FY 2023. The company's net income increased by 42%, showcasing its ability to optimize costs and improve operational efficiency. Despite this resilience, Intershop Holding faces significant challenges, including a forecasted flat revenue growth over the next two years.

Empress Royalty Reports Profitability in 2024 Earnings Δ1.82

Empress Royalty's full-year 2024 earnings report shows a significant turnaround from the previous year, with revenue increasing by 128% to US$8.02m and net income rising to US$1.01m, compared to a loss of US$2.93m in FY 2023. The company's profit margin improved to 13%, driven by higher revenue, which led to an earnings per share (EPS) of US$0.009, up from a loss of US$0.025 in FY 2023. This marked a successful transition for the company, following its efforts to strengthen its operations and improve financial performance.

Flughafen Zürich Full Year 2024 Earnings: EPS Misses Expectations Δ1.81

Flughafen Zürich reported a revenue increase to CHF1.33 billion for the full year 2024, reflecting a 7.3% growth from the previous year, while net income also rose by 7.4% to CHF326.7 million. Despite these positive revenue figures, the earnings per share (EPS) of CHF10.64 fell short of analyst expectations by 1.4%. Looking ahead, the company anticipates an average revenue growth of 4.3% per annum over the next three years, outpacing the broader infrastructure industry's forecast in Europe.

Schroders Full Year 2024 Earnings: Beats Expectations Δ1.81

Schroders' full year 2024 earnings have exceeded analyst estimates by 1.0%, with revenue rising to UK£3.02 billion (up 1.0% from FY 2023). The company's net income also surged to UK£417.0 million (up 7.4% from FY 2023), driven by strong profit margins of 14%. These results demonstrate Schroders' ability to navigate challenging market conditions and deliver solid performance.

The Future of Pearson's Growth Depends on Its Balance Sheet Δ1.81

Pearson's full-year 2024 earnings report shows a mixed bag, with revenue down 3.3% and EPS beating estimates by 14%. The company's profit margin increased to 12%, driven by lower expenses, but this growth is not translating to the bottom line as expected. Despite missing analyst revenue estimates, Pearson's share price remains unchanged.

Methanex Full Year 2024 Earnings: Misses Expectations Δ1.81

Methanex reported its full year 2024 financial results, revealing flat revenue of $3.72 billion and a 5.8% decline in net income to $164 million, falling short of analyst expectations. The company's earnings per share also missed forecasts by 17%, reflecting a profit margin decrease from 4.7% to 4.4%. Despite these setbacks, Methanex anticipates a 10% annual revenue growth over the next three years, outpacing the broader Canadian chemicals industry.